Pfizer works across markets to develop wellness, prevention, treatments, and cures, providing access to healthcare through collaboration with governments, corporate partners, healthcare providers, and local communities.
We will provide you with some of the investing attributes as of January 18, 2022, from Yahoo Finance:– Market Capitalization: $303.6 Billion– Average Volume: 43,340,212– Trailing P/E Ratio (TTM): 15.45– Forward P/E Ratio: 11.07– 52 Week H/L Range: $33.36-$61.71– Dividend Yield: 2.96%– Beta: 0.64
The price-earnings or PE ratio is the current market price divided by the company’s earnings per share or EPS. This ratio is the primary benchmark of valuing a stock, demonstrating how expensive the shares are relative to the company’s profits.
Pfizer’s dividend yield is the annual cash dividend paid of $1.60 per share to an investor as a percentage of its current market price, or 2.96%. This yield is above average compared to the S&P 500’s rate.